Rafferty Asset Management, LLC Immuno Gen, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $3.23 Million - $7.78 Million	-259,616 Reduced 45.79%	307,369 $9.11 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $3.24 Million - $4.56 Million	229,699 Added 68.1%	566,985 $9 Million
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $3.87 Million - $20.7 Million	-1,030,684 Reduced 75.34%	337,286 $6.36 Million
Q1 2023 May 11, 2023	SELL	$3.67 - $4.92 $891 - $1,195	-243 Reduced 0.02%	1,367,970 $5.25 Million
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $1.91 Million - $2.66 Million	420,762 Added 44.41%	1,368,213 $6.79 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $893,468 - $1.29 Million	199,435 Added 26.66%	947,451 $4.53 Million
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $330,334 - $604,039	-104,868 Reduced 12.3%	748,016 $3.37 Million
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $1.87 Million - $3.29 Million	439,850 Added 106.49%	852,884 $4.06 Million
Q4 2021 Feb 10, 2022	BUY	$4.75 - $7.5 $521,269 - $823,057	109,741 Added 36.18%	413,034 $3.07 Million
Q3 2021 Nov 10, 2021	SELL	$5.02 - $6.59 $498,250 - $654,077	-99,253 Reduced 24.66%	303,293 $1.72 Million
Q2 2021 Aug 10, 2021	BUY	$5.79 - $8.6 $143,499 - $213,142	24,784 Added 6.56%	402,546 $2.65 Million
Q1 2021 May 10, 2021	BUY	$6.5 - $10.53 $1.94 Million - $3.14 Million	298,247 Added 375.08%	377,762 $3.06 Million
Q4 2020 Feb 10, 2021	SELL	$3.7 - $7.66 $553,538 - $1.15 Million	-149,605 Reduced 65.3%	79,515 $513,000
Q3 2020 Nov 13, 2020	BUY	$3.45 - $4.89 $441,368 - $625,592	127,933 Added 126.43%	229,120 $825,000
Q2 2020 Aug 07, 2020	BUY	$3.32 - $5.34 $287,332 - $462,155	86,546 Added 591.12%	101,187 $465,000
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $232,504 - $745,769	-109,672 Reduced 88.22%	14,641 $50,000
Q4 2019 Feb 10, 2020	SELL	$2.25 - $5.8 $440,271 - $1.13 Million	-195,676 Reduced 61.15%	124,313 $635,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $3.39 $710,375 - $1.08 Million	319,989 New	319,989 $774,000
Q2 2019 Aug 09, 2019	SELL	$1.8 - $3.3 $1.3 Million - $2.39 Million	-722,765 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $1.74 Million - $4.27 Million	722,765 New	722,765 $1.96 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account